Login to Your Account

Favorable Climate for New Antibiotics

ICAAC Focuses on New Drug Pipeline and Combatting MDR

By Peter Winter

Monday, September 9, 2013

A great deal has transpired in the antibiotics world since the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) last convened one year ago. As researchers and antibiotic drug developers alike head to Denver this week for this annual meeting the focus will be squarely on new product pipeline progress and whether these innovative products nearing the marketplace will be enough to alleviate the growing concern about multidrug drug resistance in virulent bacteria.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription